Erratum: A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin (Diabetologia DOI: 10.1007/s00125-012-2686-y);A high-Fat-Diet-Induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3061-3070

  McNeilly, A D ^a   Williamson, R ^a   Balfour, D J K ^a   Stewart, C A ^a   Sutherland, C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Alzheimer's; Brain; Dementia; Diet; Insulin; Metformin; Signalling

Indexed keywords

INSULIN; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHALAMUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPSE; WEIGHT GAIN;

EID: 84867575440     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2761-4     Document Type: Erratum

References (49)

1. Allen KV, Frier BM, Strachan MWJ (2004) The relationship between T2DM and cognitive dysfunction: Longitudinal studies and their methodological limitations. Eur J Pharmacol 490: 169-175
2. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666
3. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Kruegeer K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:656-663
4. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer's disease. Neurology 63:1187-1192
5. Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82:510-529
6. Strachan MW (2005) Insulin and cognitive function in humans: Experimental data and therapeutic considerations. Biochem Soc Trans 33:1037-1040
7. Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: Review and hypothesis. Neurobiol Aging 27:190-198
8. Zhao L, Teter B, Morihara T et al (2004) Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention. J Neurosci 24:11120-11126
9. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: A drug target for CNS therapies. J Neurochem 89:1313-1317
10. Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102
11. Suzuki R, Lee K, Jing E et al (2010) Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 12: 567-579
12. Lue LF, Yan SD, Stern DM, Walker DG (2005) Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 4:249-266
13. Yaffe K, Lindquist K, Schwartz AV et al (2011) Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 77:1351-1356
14. Wessels AM, Lane KA, Gao S, Hall KS, Unverzagt FW, Hendrie HC (2011) Diabetes and cognitive decline in elderly African Americans: A 15-year follow-up study. Alzheimers Dement 7:418-424
15. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CPJ, Yaffe K (2005) Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330:1360
16. Bruehl H, Sweat V, Tirsi A, Shah B, Convit A (2011) Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions. Neurosci Med 2:34-42
17. Greenwood CE, Winocur G (2001) Glucose treatment reduces memory deficits in young adult rats fed high-fat diets. Neurobiol Learn Mem 75:179-189
18. McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546-553
19. Niswender KD, Baskin DG, Schwartz MW (2004) Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol Metab 15:362-369
20. Vanhaesebroeck B, Leevers SJ, Ahmadi K et al (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602
21. Lawlor MA, Alessi DR (2001) PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910
22. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of GSK3 by insulin mediated by protein kinase B. Nature 378:785-789
23. Sutherland C (2011) What are the bona fide substrates of GSK3? Int J Alzheimers Dis 2011:505607
24. Sutherland C, O'Brien RM, Granner DK (1997) Regulation of gene transcription by insulin and the search for diabetogenes. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (eds) International textbook of diabetes mellitus. Wiley, Chichester, pp 489-504
25. Stern MP (1997) The insulin resistance syndrome. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (eds) International textbook of diabetes mellitus. Wiley, Chichester, pp 255-286
26. Withers DJ, White M (2000) Perspective: The insulin signaling system-a common link in the pathogenesis of type 2 diabetes. Endocrinology 141:1917-1921
27. Lazar MA (2005) How obesity causes diabetes: Not a tall tale. Science 307:373-375
28. Um SH, D'Alessio D, Thomas G (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3:393-402
29. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-S73
30. Ho L, Qin W, Pompl PN et al (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18:902-908
31. Julien C, Tremblay C, Phivilay A et al (2010) High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 31:1516-1531
32. Takeda S, Sato N, Uchio-Yamada K et al (2010) Diabetesaccelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107:7036-7041
33. Diaz B, Serna J, de Pablo F, de la Rosa EJ (2000) In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. Development 127:1641-1649
34. Wu X, Reiter CE, Antonetti DA, Kimball SR, Jefferson LS, Gardner TW (2004) Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J Biol Chem 279: 9167-9175
35. Watson GS, Craft S (2006) Insulin resistance, inflammation, and cognition in Alzheimer's disease: Lessons for multiple sclerosis. J Neurol Sci 245:21-33
36. Craft S (2006) Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20:298-301
37. Wallum BJ, Taborsky GJ Jr, Porte D Jr et al (1987) Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 64:190-194
38. Schafer M, Erdo SL (1991) Development of glutamate neurotoxicity in cortical cultures: Induction of vulnerability by insulin. Brain Res Dev Brain Res 62:293-296
39. Freude S, Plum L, Schnitker J et al (2005) Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 54: 3343-3348
40. McNeilly AD, Williamson R, Sutherland C, Balfour DJ, Stewart CA (2011) High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav Brain Res 217: 134-141
41. Liu A, Coleman SP (2009) Determination of metformin in human plasma using hydrophilic interaction liquid chromatographytandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:3695-3700
42. Logie L, Ruiz-Alcaraz AJ, Keane M et al (2007) Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells. Diabetes 56:2218-2227
43. Greenwood CE, Winocur G (2005) High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 26:42-45
44. Nagahama Y, Okina T, Suzuki N et al (2003) Factor structure of a modified version of the wisconsin card sorting test: An analysis of executive deficit in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16:103-112
45. Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29:345-351
46. Hundal RS, Inzucchi SE (2003) Metformin: New understandings, new uses. Drugs 63:1879-1894
47. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, ForetzM, Andreelli F (2012) Cellular and molecular mechanisms of metformin: An overview. Clin Sci (Lond) 122:253-270
48. Kickstein E, Krauss S, Thornhill P et al (2010) Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A 107:21830-21835
49. Ayala JE, Samuel VT, Morton GJ et al (2010) Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 3:525-534